The Cheapest Stocks in the World (2026): What Value Investing Says About Buying Cheap

"Buy cheap" is the oldest idea in investing — and one of the most misunderstood. A low P/E is not automatically a bargain, and a high one is not automatically expensive. This guide explains what the great value investors actually mean by cheap, why buying below intrinsic value has worked over the long run, how to avoid the traps, and which stocks screen cheapest right now on our data.

Why cheap matters: what the literature says

The intellectual foundation is Benjamin Graham's The Intelligent Investor (1949). Two ideas do most of the work. The first is the margin of safety: buy a business for meaningfully less than your conservative estimate of its worth, so that even if you are wrong, the discount protects you. The second is Mr. Market — the manic-depressive partner who quotes you a price every day; his mood, not the value of the business, is what swings. Your job is to exploit his pessimism, not catch it.

Graham's most famous student put it in one line. "Price is what you pay; value is what you get," wrote Warren Buffett in his 2008 letter — a reminder that the two are not the same, and that the gap between them is where returns come from. Buffett's refinement over pure Graham was quality: he would rather own "a wonderful company at a fair price than a fair company at a wonderful price." Cheapness and quality are not opposites; the prize is both.

Joel Greenblatt turned this into a formula in The Little Book That Still Beats the Market (2006). His "Magic Formula" ranks stocks on two axes: a high earnings yield (operating earnings relative to enterprise value — i.e. cheap) and a high return on capital (i.e. good). Cheap-and-good, bought as a basket and held with discipline, beat the market handily in his backtests. The lesson for a screen: cheapness is necessary, but pair it with a quality gauge.

And the evidence is not just anecdotal. Eugene Fama and Kenneth French (1992) documented a persistent value premium: over long horizons, cheaper stocks (high book-to-market) have on average outperformed expensive ones. The premium is not free — it shows up with painful stretches of underperformance, which is precisely why it survives. If cheap stocks always won, everyone would own them and the edge would vanish.

Our data: did cheap actually beat expensive?

We tested this on our own data. We took 207 issuers (commodity-heavy — that is where we have full price and filing history), ranked them by EV/EBITDA on 2025-07-16, and measured the next 12 months' return (to 2026-07-15). The cheapest third returned a median 42.4% versus 28.1% for the priciest third (median EV/EBITDA 4.3x vs 20.8x).

Honest caveats: this is one unusual year (a strong commodity and value rally), the sample skews to commodities, and on the mean (not median) the priciest third actually won, on a few tail winners. Once you control for EBITDA growth the cheap edge narrows (among high-growth names the cheaper half returned 20.4% vs 23.4% for the pricier half). One year is an illustration, not proof — the durable evidence is the multi-decade academic record above. This observation is recomputed daily.

What re-rating looks like: names that traded near ~2x EV/EBITDA a year ago and their subsequent return. For several, EBITDA barely grew — so the gains came from multiple re-rating, not earnings:

How to actually measure "cheap"

P/E is the household name, but it has blind spots: it ignores debt and is distorted by one-off items and tax. Two better gauges:

• EV/EBITDA compares the whole enterprise (equity plus net debt) to its cash operating profit. Because it is neutral to capital structure and tax, it lets you compare a debt-heavy miner with a debt-free software firm on the same footing. It is our default cheapness screen.
• Earnings yield (EBIT/EV) — Greenblatt's measure — is essentially EV/EBIT flipped, and answers "what operating return am I buying per dollar of enterprise value?"

We compute EV/EBITDA, P/E, P/B, ROE and dividend yield for every issuer we cover, daily, from filings — so you can rank the whole universe. The chart below shows the cheapest names on EV/EBITDA right now:

The cheapest stocks right now

These are the lowest-EV/EBITDA names across the markets we cover, excluding financials (banks distort EV/EBITDA). Treat this as a starting list to research, not a buy list — click any name for its full financials.

For a pure earnings-multiple view, the lowest-P/E names:

The value trap: cheap for a reason

The danger with buying cheap is the value trap — a stock that is cheap because the business is deteriorating, and stays cheap, or gets cheaper. A low multiple on collapsing earnings is not a bargain; it is a warning. This is why Greenblatt pairs cheap with quality, and why Buffett drifted toward durable franchises. Before acting on a low multiple, ask: Are the earnings real and sustainable (check ROE, free cash flow, debt)? Is the industry in secular decline? Is management allocating capital sensibly? A cheap price only helps if the value underneath it is intact.

How to use a cheap-stock screen

A screen is a starting point, not an answer. It narrows thousands of names to a shortlist worth real work. From here: read the filings, sanity-check the multiple against the balance sheet, look for the quality signals above, and diversify — the value premium is a portfolio phenomenon, not a single-stock guarantee. This guide is analysis, not investment advice.

Screen the whole market

Build your own shortlist on our screeners — cheapest by EV/EBITDA, lowest P/E, highest dividend yield, highest ROE — and see how entire markets compare on the global valuation map. Everything is computed daily from primary filings.